Indoco Remedies Share Price

₹ 214.94

-₹0.70 (-0.32%)
1D
Last updated 03 Nov, 2026, 13:09 IST
NSE: INDOCO
|
Pharmaceuticals

Indoco Remedies Share Price Today

As of 3 Nov 2026, Indoco Remedies share price is ₹214.94. The stock opened at ₹215.64, compared to its previous close of ₹215.64. During today's trading session, Indoco Remedies share price moved in the range of ₹213.16 to ₹217.37, with an average price of ₹215.26 for the day. Looking at its last 52-week, the stock has touched a low of ₹162.19 and a high of ₹288.00. On the performance front, Indoco Remedies share price has increased by 2.94% over the last six months and is down 22.75% on a year-on-year basis.

Share price over the last 1 day fell from 216.00 to 214.94, ranging between 213.30 and 217.37.
₹213.16
0.32% down today
₹217.37
1D LOW
1D HIGH

Indoco Remedies Stock Insights

Latest Earning
Op Profit TrendDown by 68.88% QoQ
Latest Earning
Net Profit TrendDown by 70.25% QoQ
Latest Earning
Revenue TrendUp by 11.17% QoQ
Stock Performance
OutperformingBeat Nifty by 0.36 % in last 3 month
Shareholding Pattern
PromoterPromoter increased stake by 0.10%
Shareholding Pattern
DIIDII decreased stake by 62.25%
Shareholding Pattern
FIIFII increased stake by 28.85%
Indoco Remedies stock performance
Open₹215.64
High₹217.37
Low₹213.16
Prev. close₹215.64
Indoco Remedies trading activity
Volume37,416
Average traded price₹214.79
Last traded time01:09:12 03 Nov
Last traded quantity3
Circuit
L
H
₹172.52
₹258.76
52-week
L
H
₹162.19
₹288.00
Mkt Cap Cr
1,992.69
P/E
62.75
P/B
1.95
ROA
1.22%
ROE
-7.71%
ROCE
1.93%
Quick Ratio
0.75
EV/EBITDA
9.61

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Indoco Remedies has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Indoco Remedies appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Indoco Remedies earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Indoco Remedies Company Background

ISIN
INE873D01024
Sector Market Cap
₹ 1,992.69 Cr

Indoco Remedies Limited is an India-based fully integrated, research-oriented pharmaceutical company. The Company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The Company caters to both Domestic and International markets. Its products include SENSODENT-K, HOMIDE, DEXOREN-S, LORCHEK-MR, SENSOFORM, KIDODENT, NINAF, KARVOL PLUS, CYCLOPAM, LIGNOX+ADRENLINE, NOXA, CITAL-UTI, RENOLEN, REXIDIN-M, CITAL, SENSODENT-KF, CARMICIDE, TOBAREN-DM, FEBREX PLUS, SCABEX, CLOBEN-G, MOFLOREN-BF, OTOREX, ZINCOREN, SENOLIN, LIGNOX, HEMSYL, FEDRIS, REXIDIN, VEPAN, OXIPOD, TURBOCORT, MACUCHEK, and DENTOGEL. The Company has around 11 manufacturing facilities, seven for finished dosage forms (FDFs) and four for active pharmaceutical ingredients (APIs), supported by a research and development center and a clinical research organization facility.

Indoco Remedies Financial Highlights

  • Revenue: Indoco Remedies reported revenue of ₹1,848.65 crore in FY26 vs ₹1,670.37 crore in FY25. It showed an increase of 10.67% on a yearly basis.
  • Operating Profit: Indoco Remedies reported an operating loss of ₹106.51 crore in FY26 vs ₹74.37 crore in FY25. It showed a decrease of 43.22% on a year-on-year basis.
  • Net Profit: Indoco Remedies reported a net loss of ₹98.70 crore in FY26 vs ₹77.95 crore in FY25. It showed a decrease of 26.62% on a yearly basis.

Indoco Remedies Quarterly Result Highlights

  • Indoco Remedies reported revenue of ₹522.14 crore in Sep 2026, compared with ₹469.68 crore in Jun 2026, representing an increase of 11.17% on a quarter-on-quarter (QoQ) basis.
  • Indoco Remedies reported an operating profit of ₹24.19 crore in Sep 2026, compared with ₹77.72 crore in Jun 2026, representing a decrease of 68.88% on a quarter-on-quarter (QoQ) basis.
  • Indoco Remedies reported a profit of ₹19.47 crore in Sep 2026, compared with ₹65.44 crore in Jun 2026, reflecting a decrease of 70.25% on a QoQ basis.
  • The earnings per share (EPS) of Indoco Remedies stood at ₹10.70 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
58.92%
FII
1.64%
Other DII
0.20%
Retail and other
22.80%
Mutual funds
16.44%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20251.10%
Mar 20260.94%
Jun 20261.27%
Sep 20261.64%

Indoco Remedies Investment Returns

1 day
+3.52%
1 week
-1.76%
1 month
-14.34%
1 year
-22.75%
3 years
-31.96%
5 years
-52.84%

Indoco Remedies Share Price History

Indoco Remedies share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹208.80 / ₹215.64
+3.52%
30 Oct 26
₹208.65 / ₹208.30
-0.57%
29 Oct 26
₹214.25 / ₹209.50
-1.99%
28 Oct 26
₹219.20 / ₹213.75
-3.13%
Show more

Indoco Remedies Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,845.32₹1,664.92₹1,817.29₹1,668.61
Other Income₹3.33₹5.45₹9.85₹2.34
Total Revenue₹1,848.65₹1,670.37₹1,827.13₹1,670.95
Total Expenses₹1,952.20₹1,745.74₹1,702.86₹1,478.15
Profit Before Tax-₹106.50-₹74.37₹135.80₹192.79
Tax-₹7.81₹3.58₹38.79₹50.54
Profit After Tax-₹98.68-₹77.95₹97.00₹142.25
EPS - Basic-₹10.70-₹8.46₹10.53₹15.44
EPS - Diluted-₹10.69-₹8.45₹10.51₹15.42

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹103.55-₹75.36₹124.27₹192.79
Income before WC changes₹146.43₹108.27₹261.82₹313.67
Change in Assets-₹165.78-₹48.15-₹145.24-₹61.45
Change in Liabilities₹220.69₹50.94₹58.07-₹11.74
Change in WC₹54.91₹2.79-₹87.16-₹73.19
Cash flow from Operations₹192.23₹94.94₹156.70₹178.83
Cash flow from Investing-₹101.61-₹339.11-₹433.83-₹208.17
Cash flow from Financing-₹76.79₹241.42₹280.43₹22.80
Total Cash Flow₹13.82-₹2.75₹3.31-₹6.54
Cash (Start of the year)₹12.11₹14.86₹10.92₹17.47
Cash (End of the year)₹25.93₹12.11₹14.86₹10.92

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,399.91₹1,428.57₹1,190.06₹844.63
Current Assets₹1,193.35₹1,001.35₹954.67₹813.57
Total Assets₹2,593.27₹2,429.91₹2,144.73₹1,658.20
Current Liabilities₹1,052.54₹807.99₹612.33₹424.51
Net Current Asset₹140.81₹193.35₹342.34₹389.06
Non-Current Liabilities₹608.61₹603.54₹421.90₹205.44
Equity Capital₹932.11₹1,018.38₹1,110.50₹1,028.25
Total Equity & Liabilities₹2,593.27₹2,429.91₹2,144.73₹1,658.20

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,686.07₹1,518.19₹1,790.81₹1,666.69
Other Income₹29.64₹18.48₹8.51₹2.33
Total Revenue₹1,715.71₹1,536.67₹1,799.32₹1,669.02
Total Expenses₹1,724.30₹1,545.04₹1,657.62₹1,477.43
Profit Before Tax-₹11.45-₹7.38₹153.23₹191.59
Tax-₹5.82₹1.36₹36.58₹50.23
Profit After Tax-₹5.63-₹8.74₹116.64₹141.36
EPS - Basic-₹0.61-₹0.95₹12.66₹15.34
EPS - Diluted-₹0.61-₹0.95₹12.64₹15.32

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹8.59-₹8.37₹141.70₹191.59
Income before WC changes₹169.59₹138.85₹271.78₹312.47
Change in Assets-₹156.70-₹36.94-₹95.81-₹61.47
Change in Liabilities₹222.25₹21.05₹18.39-₹10.82
Change in WC₹65.55-₹15.89-₹77.42-₹72.29
Cash flow from Operations₹226.35₹107.36₹176.78₹178.79
Cash flow from Investing-₹87.38-₹276.39-₹301.70-₹208.51
Cash flow from Financing-₹133.09₹168.62₹122.40₹22.81
Total Cash Flow₹5.87-₹0.41-₹2.52-₹6.91
Cash (Start of the year)₹7.06₹7.47₹9.99₹16.90
Cash (End of the year)₹12.94₹7.06₹7.47₹9.99

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,251.39₹1,262.28₹1,060.39₹847.21
Current Assets₹1,113.72₹938.88₹900.21₹812.47
Total Assets₹2,365.11₹2,201.16₹1,960.61₹1,659.67
Current Liabilities₹875.47₹695.01₹562.25₹427.24
Net Current Asset₹238.24₹243.87₹337.96₹385.23
Non-Current Liabilities₹390.44₹402.79₹271.74₹205.41
Equity Capital₹1,099.19₹1,103.36₹1,126.62₹1,027.02
Total Equity & Liabilities₹2,365.11₹2,201.16₹1,960.61₹1,659.67
* All values are in INR Crore
Indoco Remedies market depth
Bid quantityBid priceAsk priceAsk quantity
18214.71214.961
90214.7214.9710
49214.65214.9810
1214.53214.997
3214.52215487
Total bid quantity161
Total ask quantity515
Indoco Remedies technical summary
Bearish indicators1
Neutral indicators6
Bullish indicators1
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
39.42
Neutral
ATR (14)
12.28
Neutral
STOCH(9,6)
31.28
Neutral
STOCH RSI (14)
35.03
Neutral
ADX(9)
14.64
Bullish
UO(9)
37.37
Neutral
ROC(12)
-7.98
Bearish
WillR(14)
-79.49
Neutral
Period
Simple value
Exponential vaue
5D
213.57
214.72
10D
220.74
219.83
20D
229.59
227.56
50D
241.07
234.71
100D
237.65
232.68
Volume trend — traded volume by day
3 Nov0L
2 Nov0L
30 Oct0L
29 Oct1L
28 Oct1L
27 Oct17L
Average3L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Indoco Remedies
Pharmaceuticals
Add Stock
Add Another

Indoco Remedies Returns Calculator

Ex-date: 10 Sep 2026

Top Gainers

AEGISLOG Share Price
₹1243.00
+142.9 (+12.99%)
KRBL Share Price
₹398.50
+35.5 (+9.78%)
BALRAMCHIN Share Price
₹654.65
+54.75 (+9.13%)
MARICO Share Price
₹862.20
+63.65 (+7.97%)
LODHA Share Price
₹1068.00
+65.2 (+6.5%)
See more

Top Losers

KEC Share Price
₹314.00
-35 (-10.03%)
GNFC Share Price
₹472.00
-39 (-7.63%)
PRAJIND Share Price
₹258.35
-12.78 (-4.71%)
GESHIP Share Price
₹1533.60
-66.8 (-4.17%)
NATIONALUM Share Price
₹316.95
-11.05 (-3.37%)
See more

Indoco Remedies Share Price FAQs

Please be aware that Indoco Remedies stock prices are subject to continuous fluctuations due to various factors.